Absci (ABSI) Capital Expenditures (2020 - 2026)
Absci (ABSI) reported Capital Expenditures of $30000.0 for Q1 2026, up 20.0% on a YoY basis from $25000.0 in Q1 2025, and up 129.13% sequentially from -$103000.0 in Q4 2025.
Absci (ABSI) Capital Expenditures (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Capital Expenditures data on file, last reported at $30000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 20.0% year-over-year to $30000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 159.21% YoY), and the FY2025 full-year result was $1.1 million, up 174.01% from the prior year.
- Capital Expenditures grew to $30000.0 in Q1 2026, from -$103000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $13.6 million in Q3 2022 to a low of -$15.6 million in Q4 2022.
- A 5-year average of $101866.7 and a median of $30000.0 in 2026 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 10356.25% in 2022, while the deepest fall reached 321.69% in 2022.
- Tracing ABSI's Capital Expenditures over 5 years: stood at -$15.6 million in 2022, then surged by 99.5% to -$78000.0 in 2023, then jumped by 525.64% to $332000.0 in 2024, then sank by 131.02% to -$103000.0 in 2025, then soared by 129.13% to $30000.0 in 2026.
- Business Quant data shows ABSI's Capital Expenditures at $30000.0 in Q1 2026, -$103000.0 in Q4 2025, and $962000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -103,000.00 |
| Dec 31, 2025 | -103,000.00 |
| Sep 30, 2025 | 962,000.00 |
| Sep 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 223,000.00 |
| Jun 30, 2025 | 223,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Sep 30, 2024 | -261,000.00 |
| Sep 30, 2024 | -261,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Jun 30, 2024 | 333,000.00 |
| Sep 30, 2023 | -78,000.00 |
| Sep 30, 2023 | -78,000.00 |
| Jun 30, 2023 | -48,000.00 |
| Jun 30, 2023 | -48,000.00 |